1,522 followers
Responses to #pembrolizumab monotherapy have certainly been seen in a variety of sarcoma subtypes. The SARC28 study saw multiple UPS responses, but also responses in DD liposarcoma as well (3/10). https://t.co/7EWZofQPtU
Responses to #pembrolizumab monotherapy have certainly been seen in a variety of sarcoma subtypes. The SARC28 study saw multiple UPS responses, but also responses in DD liposarcoma as well (3/10). https://t.co/7EWZofQPtU
RT @TheLancetOncol: Pembrolizumab in advanced soft-tissue #sarcoma and bone sarcoma #scmsm https://t.co/rxhFvUdXDv
RT @MOCBrasil: Pembrolizumabe ativo nos Sarcomas de Partes Moles metastático, com TRO 18% em estudo Fase 2 https://t.co/hebcioNSzJ @Melanom…